Cargando…
A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer
Pembrolizumab, an anti-programmed death-1 specific monoclonal antibody is a second-line treatment for metastatic urothelial carcinoma. Physicians should be aware of adverse immune-related events associated with the use of immune checkpoint inhibitors, particularly adrenocortical insufficiency, which...
Autores principales: | Nagai, Takashi, Mogami, Tohru, Takeda, Tomoki, Tomiyama, Nami, Yasui, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273353/ https://www.ncbi.nlm.nih.gov/pubmed/34285878 http://dx.doi.org/10.1016/j.eucr.2021.101766 |
Ejemplares similares
-
Children with isolated growth hormone deficiency: Empty sella versus normal sella
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2013) -
Development of an Empty Sella
por: Chen Cardenas, Stanley M, et al.
Publicado: (2023) -
A young man with secondary adrenal insufficiency due to empty sella syndrome
por: Chen, Hsi-Chih, et al.
Publicado: (2022) -
Prognosis of Hormonal Deficits in Empty Sella Syndrome Using Neuroimaging
por: Atci, Ibrahim Burak, et al.
Publicado: (2018) -
Macroprolactinemia and Empty Sella Syndrome
por: Taieb, Ach, et al.
Publicado: (2017)